Clinical trial
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth
NCT06664554 is registered in ClinicalTrials.gov with HBI Solutions Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of Maternal Blood Protein Signatures in Preterm Birth
- Lead sponsor
- HBI Solutions Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- June 30, 2024
- Enrollment
- 18,000 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
preterm birth